MedTrace Logo

Validation of a Multi-gene Test for Lung Cancer Risk

NCT01130285 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2025-06-10

No results posted yet for this study

Summary

The purpose of this study is to determine the validity of a multi-gene Lung Cancer Risk Test (LCRT). In the process, the investigators will establish a bank of NBEC samples and corresponding blood samples from individuals demographically at increased risk for lung cancer.

Conditions

Interventions

GENETIC

Lung Cancer Risk Test

Measurement of gene expression in normal bronchial epithelial cells obtained at time of bronchoscopy.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Toledo Health Science Campus

    lead OTHER

Principal Investigators

  • James Willey, MD · University of Toledo Health Science Campus

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2026-08-31
Completion
2026-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01130285 on ClinicalTrials.gov